Riskpilot← Back to searchSign inGet full accessSENTRUM FYSIOTERAPI BODØ AS
ASActiveOrg 913115759Sjøgata 5, 8006 BodøPhysiotherapy activities · NACE 8695Est. 20140 employeeswww.fysiobodo.no
Revenue 2024
NOK 1M
-2% vs 2023
EBITDA margin
-5.5%
-219% vs 2023
Equity ratio
40.1%
Financial strength
Net profit 2024
NOK -61K
-272% vs 2023
| Revenue | NOK 1M | -2% |
| EBITDA | NOK -56K | -219% |
| Net profit | NOK -61K | -272% |
| Total assets | NOK 408K | +167% |
| Equity | NOK 164K | -27% |
| Employees | 0 | — |
Legal name
SENTRUM FYSIOTERAPI BODØ AS
Org number
913115759
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
24. januar 2014
Share capital
NOK 37 500
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drive et kontorfellesskap, samt utøve service overfor stifternes selskaper og det som står i naturlig tilknytning til dette.
Address
Sjøgata 5, 8006 Bodø
Website
www.fysiobodo.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 900 | 949 | 966 | 1 031 | 1 015 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 110 | 28 | 17 | 47 | −56 |
| Depreciation & amort. | −10 | −10 | −0 | −1 | −7 |
| EBIT | 100 | 18 | 17 | 46 | −62 |
| Net financials | −0 | −0 | −0 | 0 | −0 |
| Profit before tax | 100 | 18 | 17 | 46 | −63 |
| Tax | 23 | 4 | 4 | 10 | −1 |
| Net profit | 76 | 14 | 13 | 36 | −61 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 195 | 190 | 199 | 153 | 408 |
| Equity | 162 | 176 | 189 | 225 | 164 |
| Long-term debt | 0 | 0 | 0 | 1 | 0 |
| Short-term debt | 32 | 14 | 10 | −74 | 244 |
| Total debt | 32 | 14 | 10 | −72 | 244 |
EBITDA margin
-5.5%
This company
15.8%
Market median
-135% vs market
20202024
Equity ratio
40.1%
This company
38.2%
Market median
+5% vs market
20202024
Return on equity
-37.4%
This company
18.4%
Market median
-303% vs market
20202024
Net profit margin
-6.0%
This company
8.1%
Market median
-174% vs market
20202024
Asset turnover
2.49×
This company
1.12×
Market median
+122% vs market
20202024
Debt / equity
1.49×
This company
0.62×
Market median
-140% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2019 | |
| Board of Directors | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2022 | |
| Company | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Company | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SENTRUM FYSIOTERAPI BODØ AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jannike Persson | Board of Directors | 0 companies |
| Øyvind Grubstad | Board of Directors | 0 companies |